Fmr LLC Indaptus Therapeutics, Inc. Transaction History
Fmr LLC
- $1.52 Trillion
- Q2 2024
A detailed history of Fmr LLC transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 79 shares of INDP stock, worth $117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79Holding current value
$117% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INDP
# of Institutions
21Shares Held
600KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$381,8340.0% of portfolio
-
Investment House LLC Las Vegas, NV102KShares$152,6310.01% of portfolio
-
Geode Capital Management, LLC Boston, MA59.3KShares$88,3700.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$67,5500.02% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44.1KShares$65,6860.01% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $12.3M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...